U.S. Markets open in 6 hrs 40 mins

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
272.44+7.89 (+2.98%)
At close: 4:03PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.17
52-Week Change 385.84%
S&P500 52-Week Change 3N/A
52 Week High 3279.54
52 Week Low 3124.53
50-Day Moving Average 3247.65
200-Day Moving Average 3194.11

Share Statistics

Avg Vol (3 month) 3880k
Avg Vol (10 day) 3507.79k
Shares Outstanding 573.84M
Float 73.28M
% Held by Insiders 10.56%
% Held by Institutions 195.18%
Shares Short (Jul 30, 2020) 4698.12k
Short Ratio (Jul 30, 2020) 41.31
Short % of Float (Jul 30, 2020) 41.21%
Short % of Shares Outstanding (Jul 30, 2020) 40.95%
Shares Short (prior month Jun 29, 2020) 4915.54k

Dividends & Splits

Forward Annual Dividend Rate 40.64
Forward Annual Dividend Yield 40.23%
Trailing Annual Dividend Rate 30.63
Trailing Annual Dividend Yield 30.24%
5 Year Average Dividend Yield 40.55
Payout Ratio 416.62%
Dividend Date 3Aug 04, 2020
Ex-Dividend Date 4Jul 27, 2020
Last Split Factor 22:1
Last Split Date 3Sep 26, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 14.69%
Operating Margin (ttm)17.33%

Management Effectiveness

Return on Assets (ttm)9.34%
Return on Equity (ttm)18.73%

Income Statement

Revenue (ttm)1.95B
Revenue Per Share (ttm)26.31
Quarterly Revenue Growth (yoy)12.20%
Gross Profit (ttm)605.7M
EBITDA 441M
Net Income Avi to Common (ttm)285.7M
Diluted EPS (ttm)3.79
Quarterly Earnings Growth (yoy)38.00%

Balance Sheet

Total Cash (mrq)445.9M
Total Cash Per Share (mrq)6.04
Total Debt (mrq)329.1M
Total Debt/Equity (mrq)20.49
Current Ratio (mrq)2.96
Book Value Per Share (mrq)21.77

Cash Flow Statement

Operating Cash Flow (ttm)419.7M
Levered Free Cash Flow (ttm)208.82M